Schedule 13G ownership disclosure

Rhythm Pharmaceuticals Inc

Security class unavailable · CUSIP: 76243J105

Event date: 2020-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,542,591
Percent of class
8.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-050946
Form type
SC 13G/A
Filer
PRIMECAP MANAGEMENT CO/CA/
CIK
CIK 763212
Filed
Apr 24, 2020
Reporting period
Mar 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub